Lenampicillin

Lenampicillin
Clinical data
Trade namesTakacillin, Varacillin
Other namesKBT-1585
Legal status
Legal status
  • Rx in Japan
Identifiers
  • (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H23N3O7S
Molar mass461.49 g·mol−1

Lenampicillin is an antibiotic drug of the penicillin class. It is a prodrug of ampicillin; after oral administration of lenampicillin, ampicillin is rapidly formed.[1]

Lenampicillin inhibits bacterial penicillin binding proteins (transpeptidase) and is effective against a wide range of bacterial infections.[2]

Lenampicillin was developed in Japan and has been marketed there.[2]

References

  1. ^ Saito A, Nakashima M (May 1986). "Pharmacokinetic study of lenampicillin (KBT-1585) in healthy volunteers". Antimicrobial Agents and Chemotherapy. 29 (5): 948–950. doi:10.1128/aac.29.5.948. PMC 284190. PMID 3729355.
  2. ^ a b "Lenampicillin". InxightDrugs. National Center for Advancing Translational Sciences.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.